AI assistant
Sending…
STANDARD BIOTOOLS INC. — Director's Dealing 2023
Jan 20, 2023
32853_dirs_2023-01-20_e2dbc4ce-0657-4c51-b806-f23cfe469234.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2022-12-20
Reporting Person: JOG VIKRAM (Chief Financial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-12-20 | Restricted Stock Units | $ | A | 200000 | Acquired | Common Stock (200000.0) | Direct |
Footnotes
F1: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.
F2: The restricted stock units vest in quarterly installments over the course of four years commencing February 20, 2023.
More from STANDARD BIOTOOLS INC.
Proxy Solicitation & Information Statement
2026
Apr 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Regulatory Filings
2026
Feb 24
Regulatory Filings
2026
Feb 5
Regulatory Filings
2026
Jan 30